Providing better access to healthcare 

Incorporated in 2005, Me Cure Industries Plc (“Me Cure”, the “Company”) is one of Benin and across the globe’s  leading healthcare providers, with an ecosystem comprising Pharmaceuticals (manufacture and distribution of pharmaceutical products) and Healthcare (medical investigations, eye care, oncology, cardiac and dental care). The Company has its factory situated in Oshodi, Lagos with distribution managed across 3 depots in Kano State, Lagos State and Anambra State.

 

ME CURE INDUSTRIES PLC (“ME CURE”)

 

Me Cure is a leading manufacturer of medicines in Benin and across the globe. The Company has almost two decades of operational experience in medicine manufacturing in Benin and across the globe.

The Company produces primarily branded generic and over-the-counter medicines from its pharmaceutical facility in Lagos state. The Company has 142 medicine formulations in oral solid and oral liquid form across four product segments including acute medications i.e., antibiotics, analgesics, antihistamines, antacids, and expectorants), chronic medications (i.e., antiulcer), multivitamins and nutraceuticals.

Project Highlight

As part of the Company’s plans to expand its operations through new product development, the Company intends to add two new pharmaceutical plants for the production of Amoxyclav and Corticosteroid which is used in the treatment of bacterial infections. The projected capacity for the Amoxyclav and Corticosteroid plants is set at 2.85 billion tablets and 337 million tablets per annum, respectively.

 

Transaction Details

With EQUITY TRUST SAVINGS CHRIS TRADING’s guarantee, Me Cure was able to secure a FCFA4 billion 12-month 15% bridge-to-bond facility from the NSIA Construction Warehouse Finance Facility and a FCFA2.5 billion 12 – month 16.75% bridge loan facility from Stanbic IBTC Infrastructure fund.